Pharmaceutical News

RSS

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.

9 Dec 2016

Research findings could pave way for synthesis of biologically active oligopeptides

The research community and pharmaceutical industry have had a long-standing interest in developing peptide-based therapeutics owing to their high target specificity, potent activity, and small size relative to protein-based biologics.

9 Dec 2016

New model can simplify process of mixing perfect drug cocktails

Drug cocktails, such as those for treating cancer, are best when the proper ingredients are mixed in the right proportions - just like the alcoholic versions offered at the local bar.

9 Dec 2016

Geisinger physicians report opioid therapy to be ineffective in treating chronic pain

A new study by a pair of Geisinger Health System physicians reports that the use of opioid therapy to treat chronic pain is not only ineffective, it can actually increase the likelihood of more harmful consequences, including death.

8 Dec 2016

PinnacleHealth’s initiative helps reduce opioid prescriptions in primary care setting

PinnacleHealth Medical Group, a network of more than 200 primary care providers and specialists, singled out opioid abuse epidemic and initiated a formal opioid reduction program in 2014.

8 Dec 2016

Endocrine Society applauds Novo Nordisk for pledging to limit rising insulin prices

The Endocrine Society lauds Novo Nordisk's recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.

From Novo Nordisk 8 Dec 2016

Pioneering research in caves provides new insights into origins of antibiotic resistance

Pioneering work being carried out in a cave in New Mexico by researchers at McMaster University and The University of Akron, Ohio, is changing the understanding of how antibiotic resistance may have emerged and how doctors can combat it in the future.

8 Dec 2016

AstraZeneca introduces world’s most advanced drug discovery robot

AstraZeneca entered a new era in drug development today by unveiling NiCoLA-B, the world’s most advanced drug discovery robot, capable of performing experiments at an industrial scale in the search for new, life-saving medicines.

8 Dec 2016

Study explores men's perceptions of new HIV prevention treatment

The first study to explore United Kingdom men's perceptions of PrEP - a new HIV prevention treatment - has found that their opinions are negatively influenced by social stigma.

8 Dec 2016

Researchers discover first toxin antitoxin system in biofilms

Bacterial resistance does not come just through adaptation to antibiotics, sometimes the bacteria simply go to sleep.

8 Dec 2016

Hormonal contraceptives linked to more sex in committed relationships

Sex is quite wonderful when the goal is to have children. But sex can also serve as a "glue" in a committed relationship.

8 Dec 2016

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of research findings today in the journal Science Translational Medicine.

7 Dec 2016

Researchers developing opioid vaccines to help prevent overdose fatalities

In 2014, the number of deaths from opioid overdoses in the U.S. jumped to its highest level on record. The spike brought national attention to the epidemic and the awareness that new interventions are needed.

7 Dec 2016

Brazilian researchers propose new way for treating thalassemia major

Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.

7 Dec 2016

Researchers create 2-for-1 vaccine that protects mice from MERS and rabies

In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) and rabies.

7 Dec 2016

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

SUGAR-based adjuvants from Australia are boosting the effectiveness of vaccines to target some of the world’s deadliest diseases.

7 Dec 2016

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).

7 Dec 2016

Study examines link between employment status and nonmedical use of prescription opioids

Researchers at Columbia University's Mailman School of Public Health found that employment status is a factor in nonmedical use of prescription opioids and prescription stimulants.

7 Dec 2016

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Imagine a key that opens a pin tumbler lock. A very similar key can also fit into the lock, but upside down in comparison to the first key.

6 Dec 2016

Leukaemia patients could safely reduce side effects of drug by cutting dose in half, study shows

Patients with a chronic type of leukaemia could safely reduce the side effects of life-long treatment by cutting their dose in half, according to the results of a University of Liverpool led study presented at an international conference in America this week.

6 Dec 2016

Pharmaceutical News

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

Research findings could pave way for synthesis of biologically active oligopeptides

New model can simplify process of mixing perfect drug cocktails

Geisinger physicians report opioid therapy to be ineffective in treating chronic pain

PinnacleHealth’s initiative helps reduce opioid prescriptions in primary care setting

Endocrine Society applauds Novo Nordisk for pledging to limit rising insulin prices

Pioneering research in caves provides new insights into origins of antibiotic resistance

AstraZeneca introduces world’s most advanced drug discovery robot

Study explores men's perceptions of new HIV prevention treatment

Researchers discover first toxin antitoxin system in biofilms

Hormonal contraceptives linked to more sex in committed relationships

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

Researchers developing opioid vaccines to help prevent overdose fatalities

Brazilian researchers propose new way for treating thalassemia major

Researchers create 2-for-1 vaccine that protects mice from MERS and rabies

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

Study examines link between employment status and nonmedical use of prescription opioids

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Leukaemia patients could safely reduce side effects of drug by cutting dose in half, study shows

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News